Clinical Trial

Best Hypnotic Drug Choice for Rapid Sequence Induction in the Operating Room

Study acronym: HYPNOTIKS
Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
The best hypnotic choice to optimize the balance between good intubation condition quality and hemodynamic stability during RSI performed in the operating theatre remained to be investigated. Therefore, a randomized study evaluating the efficacy of propofol, ketamine, and a combination of both is appropriate. So, we designed the HyPnotiKs randomized controlled study to investigate the efficacy of these hypnotic drugs in patients undergoing RSI in the operating theatre. The primary endpoint will be the successful tracheal intubation at the first attempt without major arterial hypotension event.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2024-12-09; most recent amendment 2025-11-24.
Status change: Not Yet Recruiting → Recruiting 2025-04-22
Trial Details
NCT Number NCT06733129
Lead Sponsor Nantes University Hospital
Conditions Rapid Sequence Induction
Enrollment 1,218 participants
Start Date 2025-04-14
Primary Completion 2027-04-14 (estimated)
Study Completion 2027-04-30 (estimated)
Updated on ClinicalTrials.gov 2025-12-02